Labcorp (NYSE: LH) EVP reports open-market insider stock sale

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive Sandra D. van der Vaart, EVP of Corporate Affairs, reported an open-market sale of common stock. On February 27, 2026, she sold 547.5397 shares at an average price of $284.9100 per share. After this transaction, she directly owns 2,578.9467 shares of Labcorp common stock.

Insider Trade Summary

Net Seller: 547.54 shares ($156,000)

Net Sell 1 txn

Insider van der Vaart Sandra D

Role EVP, Corporate Affairs

Sold 547.54 shs ($156K)

Type	Security	Shares	Price	Value
Sale	Common Stock	547.54	$284.91	$156K

Holdings After Transaction: Common Stock — 2,578.947 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van der Vaart Sandra D

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Affairs

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		S		547.5397	D	$284.91	2,578.9467	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Sandra D. van der Vaart	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LH report in this Form 4 filing?

Labcorp reported that executive Sandra D. van der Vaart sold 547.5397 shares of common stock. The open-market transaction occurred at an average price of $284.9100 per share and reduced her direct holdings to 2,578.9467 shares.

Who is the insider involved in the latest LH Form 4 transaction?

The insider is Sandra D. van der Vaart, Executive Vice President of Corporate Affairs at Labcorp. She reported an open-market sale of 547.5397 shares of common stock and now directly holds 2,578.9467 shares following the transaction.

How many LH shares did the Labcorp EVP sell and at what price?

Sandra D. van der Vaart sold 547.5397 shares of Labcorp common stock. The Form 4 states the sale was completed at an average price of $284.9100 per share in an open-market or private sale transaction.

How many LH shares does the reporting person own after this Form 4 sale?

Following the reported sale, Sandra D. van der Vaart directly owns 2,578.9467 shares of Labcorp common stock. This figure represents her remaining direct beneficial ownership as disclosed in the Form 4 filing after the February 27, 2026 transaction.

Was the LH insider transaction a purchase or a sale of shares?

The transaction was a sale of Labcorp common stock. The Form 4 identifies the code as “S” and describes it as an open-market or private sale transaction, with 547.5397 shares sold at an average price of $284.9100 per share.

Is the LH insider’s ownership in Labcorp direct or indirect after the sale?

After the transaction, Sandra D. van der Vaart’s reported ownership is direct. The Form 4 marks the nature of ownership as direct, showing 2,578.9467 shares of Labcorp common stock held directly in her name following the sale.